Welcome to LookChem.com Sign In|Join Free

CAS

  • or

332-42-3

Post Buying Request

332-42-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

332-42-3 Usage

Description

1-(2-BROMOETHYL)-4-FLUOROBENZENE is an organic compound that serves as a versatile intermediate in the synthesis of various pharmaceutical agents and chemical compounds. Its unique structure, featuring a bromoethyl group and a fluorine atom attached to a benzene ring, allows for a wide range of applications in the chemical and pharmaceutical industries.

Uses

Used in Pharmaceutical Industry:
1-(2-BROMOETHYL)-4-FLUOROBENZENE is used as a key intermediate in the production of protein A mimetics, which are engineered proteins that mimic the binding properties of natural protein A. These mimetics have potential applications in various therapeutic and diagnostic areas, such as antibody purification, immunoassays, and drug delivery systems.
Used in Pharmaceutical Industry:
1-(2-BROMOETHYL)-4-FLUOROBENZENE is also utilized as an intermediate in the synthesis of serotonin antagonists, which are drugs that block the action of serotonin, a neurotransmitter involved in various physiological processes. These antagonists have potential applications in the treatment of disorders such as depression, anxiety, and obsessive-compulsive disorder.
Used in Pharmaceutical Industry:
Furthermore, 1-(2-BROMOETHYL)-4-FLUOROBENZENE is employed as an intermediate in the development of other central nervous system (CNS) agents. These agents can have various therapeutic applications, such as treating neurological disorders, pain management, and cognitive enhancement.

Check Digit Verification of cas no

The CAS Registry Mumber 332-42-3 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,3 and 2 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 332-42:
(5*3)+(4*3)+(3*2)+(2*4)+(1*2)=43
43 % 10 = 3
So 332-42-3 is a valid CAS Registry Number.

332-42-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(2-BROMOETHYL)-4-FLUOROBENZENE

1.2 Other means of identification

Product number -
Other names 4-Fluorophenethyl bromide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:332-42-3 SDS

332-42-3Relevant articles and documents

Cascade bio-hydroxylation and dehalogenation for one-pot enantioselective synthesis of optically active β-halohydrins from halohydrocarbons

Cui, Hai-Bo,Xie, Ling-Zhi,Wan, Nan-Wei,He, Qing,Li, Zhi,Chen, Yong-Zheng

supporting information, p. 4324 - 4328 (2019/08/21)

A stereoselective hydroxylation and enantioselective dehalogenation cascade reaction was developed for the synthesis of optically active β-haloalcohols from halohydrocarbons. This cascade system employed P450 and halohydrin dehalogenase as two compatible biocatalysts, allowing a straightforward, greener and efficient access to β-halohydrins with excellent enantioselectivities (98-99%).

Spiroalkene carboxamide derivatives and their use as chemokine receptor modulators

-

Page/Page column 48, (2012/10/18)

The present invention is directed to compounds of Formula (I) below, which are antagonists to the chemoattractant cytokine receptor 2 (CCR2), and/or 5 (CCR5), pharmaceutical compositions, and methods for use thereof.

3-Hydroxypyrimidine-2,4-diones as an Inhibitor Scaffold of HIV Integrase

Tang, Jing,Maddali, Kasthuraiah,Metifiot, Mathieu,Sham, Yuk Y.,Vince, Robert,Pommier, Yves,Wang, Zhengqiang

, p. 2282 - 2292 (2011/06/17)

Integrase (IN) represents a clinically validated target for the development of antivirals against human immunodeficiency virus (HIV). Inhibitors with a novel structure core are essential for combating resistance associated with known IN inhibitors (INIs). We have previously disclosed a novel dual inhibitor scaffold of HIV IN and reverse transcriptase (RT). Here we report the complete structure-activity relationship (SAR), molecular modeling, and resistance profile of this inhibitor type on IN inhibition. These studies support an antiviral mechanism of dual inhibition against both IN and RT and validate 3-hydroxypyrimidine-2,4-diones as an IN inhibitor scaffold.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 332-42-3